Colombia Pre-Submission Classification Consultation with INVIMA

1. Key takeaways

A pre-submission classification consultation is not a legally mandatory step; Colombia’s current regulations set no unified processing deadline or format for it (practical estimate). Its value lies not in acceleration but in lock-in — trading a bounded, uncertain time investment for a classification conclusion that can be documented in writing, thereby avoiding directional errors in pathway, fees and timeline models. GRZAN’s judgment: the return on a consultation is proportional to the ambiguity of the product’s classification, and inversely proportional to its clarity.

One cost accounting makes this plain. A single pathway misjudgment costs: the full official fee of a refiling (321.91 UVB for Class I/IIa or 364.36 UVB for Class IIb/III), reworked technical documentation and Spanish translation, a torn-up schedule (90 business days of statutory review for Class IIb/III plus a 90-day deficiency response per round), and a delayed market-entry date. Against this, the investment in one consultation is limited and controllable. GRZAN’s position is explicit: for products with genuine classification disputes, skipping the consultation is the larger cost.

2. Legal basis

3. Expert insights

#### Four situations where asking is worthwhile

Drawing on project experience, GRZAN marks four trigger lines: first, products where two or more of the 18 rules of Art. 7 may simultaneously apply and point to different classes (combination products and drug-device boundary products, for instance); second, products such as standalone software (SaMD) where the Art. 6 mapping has a gap; third, products whose intended use spans diagnosis and treatment or whose claims sit on a blurred boundary; fourth, products already marketed abroad whose foreign classification cannot map directly onto Colombia’s four-tier system. Any one hit means the expected return of a consultation exceeds its cost.

#### Two situations where asking is not

A consultation is not a panacea, and GRZAN advises against initiating one in two situations. The first is products whose classification is fixed by a single rule of Art. 7 with no room for dispute — asking will not change the conclusion and only consumes time. The second is products whose intended use and claims the company has not yet settled — when the use is undecided, any reply is valid only for the description as submitted, and it fails the moment the use changes. The precondition of a consultation is that the company has already described its own product clearly.

#### How the consultation package is organized determines the quality of the reply

When posing a classification question to the authority, the way the materials are organized directly determines how quotable the reply will be. GRZAN’s standard practice: first present the complete derivation completed independently under Art. 6 and Art. 7, including the rules considered and excluded and the reasons for exclusion; then pose the specific classification question points; finally attach drafts of the instructions for use and labeling. This organization brings two benefits: the authority’s reply addresses the specific question points rather than speaking in generalities, and the derivation itself becomes a written basis that can be submitted with the filing.

#### The effect and the boundary of the reply

A written consultation reply is not a registration decision and produces no exemption — a boundary that must be made clear to clients. Its practical effect has three components: written support for the classification determination, an anchor for internal consistency across the filing documents, and a reference point in communication with review. GRZAN also cautions: the reply addresses only the product description submitted with the question. When the product later undergoes substantive change — an expanded intended use or adjusted technical parameters — the reply’s applicability must be reassessed, and the question re-posed if necessary.

4. Practical recommendations

1. At project initiation, the GRZAN regulatory team screens the product against the four trigger lines and delivers a consultation-necessity assessment memo stating whether to initiate.
2. Where the decision is to initiate, the technical documentation lead assembles the full package: the independent Art. 6 and Art. 7 derivation (including excluded rules and reasons), the specific question points, and drafts of the instructions for use and labeling.
3. The titular’s local apoderado submits the consultation as a Colombian entity under the Art. 29 power of attorney and retains the original written reply.
4. The project manager annotates the plan: consultations carry no statutory processing deadline (practical estimate), are managed on an open-ended cycle, and are never placed on the delivery critical path.
5. The registration team archives the written reply as classification-determination support material and keeps the filing’s wording consistent with it.
6. The product management function builds change monitoring: on substantive change of intended use or technical parameters, reassess the reply’s applicability and re-pose the question when necessary.

5. Verification checklist

• □ The consultation-necessity assessment has been completed against the four trigger lines with a written memo issued
• □ It is confirmed the product does not fall in the two situations where initiating is not advised
• □ The consultation package contains the complete independent Art. 6 and Art. 7 derivation with excluded rules explained
• □ Drafts of the instructions for use and labeling are attached, with use claims settled
• □ The local apoderado has submitted under a valid power of attorney (Art. 29) and retains the original written reply
• □ The project plan annotates that consultations carry no statutory deadline and are off the delivery critical path
• □ The written reply is archived as classification support material and the filing’s wording matches it
• □ A mechanism exists to reassess reply applicability on substantive product change

Regulatory information verified as of October 29, 2026

All external conclusions rest on the current regulatory texts published by the competent authority, verified provision by provision before delivery.

GRZAN runs INVIMA pre-submission classification consultations for the Colombian market — trigger-line screening, derivation packages and reply management — locking pathway decisions before fees and timelines are committed. For inquiries, contact info@grzanglobal.com.